CCA Industries, Inc. (OTC:CAWW)

Cca Industries  (OTC:CAWW) ($0.60; $4.5M market cap) announced Q4 2024 results

• Sales of $1.6 million vs $2.1 million in the prior year
• Non-GAAP net loss of $0.07 vs a net loss of $0.24 in the prior year

 "I will start with the most important part first.  As we wrap up the first quarter of 2025, we expect EBITDA to be profitable for the quarter.  This is a substantial jump from the first quarter of 2024 where we lost close to $300K, and we expect that trend to continue in the quarters to come.  As we said throughout 2024, it was a year of transition from a 100% brick-and-mortar retail company to a hybrid company through the growth of our online channels." Dominello continued, "We made many moves in 2024 that were hard decisions to make and others that were a bit easier, but we felt that all of them were the right ones for the future of CCA.  The Company has made some significant restructuring changes to the business, including consolidating the three warehouses we were using into one new warehouse, which lowers our operating costs.  We have already seen the results of that change in the first two months of fiscal 2025, with much lower warehouse and shipping costs, and cost of goods that decreased by approximately 5%.  As I always say, we still face challenges, but we are still clear-eyed on what we need to do and where we are going. I look forward to sharing Q1 results in the very near future."

CCA Industries, Inc. manufactures and distributes health and beauty aid products in the United States and internationally.

Cca Industries  (OTC:CAWW) ($0.83; $5.6M market cap) announced Q3 2024 results

• Sales of $1.7 million vs $2.8 million in the prior year
• Net loss of $0.06 vs a net loss of $0.06

Results via 10-Q only, we await the company’s press release for more color from management. Recall in the last release, the company mentioned 

“Neutein, our brain health supplement launched at CVS in the second quarter of fiscal 2024, giving us pipeline orders in Q3.  While we are encouraged with our achievements to date, we are still a work in progress.  We have developed plans to grow both top and bottom line and are executing them during Q3, but the benefits will likely not be felt until Q4.  These additional changes to increase our profitability will be announced later in the fourth quarter."

Cca Industries  (OTC:CAWW) ($0.82; $5.6M market cap) announced Q2 2024 results

• Sales of $2.2 million vs $2.9 million in the prior year

• Net loss of $0.00 vs a net loss of $0.02

“The EBITDA profit for the second quarter of fiscal 2024, though small, shows the beginning of our turn-around.  As a reminder, we sold the Bikini Zone brand in the fourth quarter of fiscal 2023 which had sales of $3.2 million in the first half of fiscal 2023.  Working to overcome that loss of revenue has been a focus, and our other brands have been increasing to fill the gap.  Lobe Miracle, our ear protection brand, had increased gross sales by 31.6% year over year.  Our Sudden Change skincare brand gross sales were up 20.3% year over year, and Neutein, our brain health supplement launched at CVS in the second quarter of fiscal 2024, giving us pipeline orders in Q3.  While we are encouraged with our achievements to date, we are still a work in progress.  We have developed plans to grow both top and bottom line and are executing them during Q3, but the benefits will likely not be felt until Q4.  These additional changes to increase our profitability will be announced later in the fourth quarter." 

Seems the turnaround story is progressing, we look forward to seeing what type of growth management sees come Q4.